SCHEMBL2813258

SCHEMBL2813258

COc1ccccc1OC=C(C)C(=Nc1ccc(C)cc1)Sc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 1/20 0.41
ALDH1A1 P00352 4/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2D6 P10635 1/20 0.34
HIF1A Q16665 1/20 0.34
PRSS1 P07477 1/20 0.34
ACR P10323 1/20 0.34
QRFPR Q96P65 1/20 0.34
KMT2A Q03164 4/20 0.33
MEN1 O00255 3/20 0.33
RAB9A P51151 2/20 0.33
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 3/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2813255 1.00 MAPT (0.41) MAPTHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL2816113 0.93 NOS3 (0.37) MAPTHPGDHSD17B10ALDH1A1PRSS1
SCHEMBL12851012 0.93 NOS3 (0.37) MAPTHPGDHSD17B10ALDH1A1PRSS1
SCHEMBL2816116 0.93 NOS3 (0.37) MAPTHPGDHSD17B10ALDH1A1PRSS1
SCHEMBL2808778 0.91 MAPT (0.36) MAPTHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL2808775 0.91 MAPT (0.36) MAPTHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL2815816 0.91 NOS3 (0.42) MAPTHPGDALDH1A1PRSS1ACR
SCHEMBL2815813 0.91 NOS3 (0.42) MAPTHPGDALDH1A1PRSS1ACR
SCHEMBL12851014 0.87 HTR3E (0.33) MAPTHPGDHSD17B10ALDH1A1CYP1A2
SCHEMBL2810734 0.87 HTR3E (0.33) MAPTHPGDHSD17B10ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 MAPT 4608/4885HPGD 2145/4885HSD17B10 1243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.